Absenz Oral Solution contains ethosuximide, an anticonvulsant medicine used under medical supervision to control absence seizures. The liquid formulation provides a measured alternative to capsules for patients who have been prescribed ethosuximide oral solution.
Each 1 mL contains 50 mg of ethosuximide, equivalent to 250 mg per 5 mL. Confirm the product concentration and pack details before ordering.
| Product Detail | Information |
|---|---|
| Product Name | Absenz Oral Solution |
| Active Ingredient | Ethosuximide |
| Strength | 50 mg/mL |
| Equivalent Concentration | 250 mg/5 mL |
| Dosage Form | Oral solution (liquid) |
| Therapeutic Category | Anticonvulsant |
| Main Indication | Control of absence seizures |
| Pack Size | Confirm current packaging |
| Brand/Manufacturer | Verify current product and manufacturer details |
| Prescription Status | Subject to local regulations |
Measured liquid formulation: Allows doses to be measured according to the prescription.
Established active ingredient: Contains ethosuximide, used in the management of absence seizures.
Concentration stated clearly: 50 mg/mL, equivalent to 250 mg per 5 mL.
Product verification: Buyers can request confirmation of packaging, manufacturer, batch details and expiry information before purchase.
Looking for the Absenz Oral Solution price, current stock or supply options? Request a quotation with your destination country, required quantity and requested pack size.
Before confirming an order, verify:
Current product availability and total price.
Exact concentration, bottle size and packaging.
Prescription and supporting documentation requirements.
Shipping eligibility, customs rules and local import restrictions.
International supply is not guaranteed. Brand authorization, dispensing requirements and import eligibility vary by country.
Absenz Oral Solution should be taken only at the dose and frequency prescribed by a qualified healthcare professional. The appropriate regimen depends on clinical factors, including the patient’s age, response and treatment plan.
Use a calibrated oral syringe or suitable medicine-measuring device. Do not estimate doses with household teaspoons. Do not discontinue ethosuximide suddenly without medical advice.
Common adverse effects can include nausea, vomiting, abdominal discomfort, reduced appetite, fatigue and dizziness. Ethosuximide can also cause rare but serious blood disorders and severe skin reactions.
Seek urgent medical attention for an unusual rash, blistering, facial swelling, breathing difficulty, persistent fever, sore throat, unexplained bruising or other signs of serious illness. Inform the prescriber about other medicines, allergies, pregnancy or breastfeeding.
Prescription use and ongoing medical monitoring are essential. Refer to the supplied product leaflet and a healthcare professional for complete safety information.
Absenz is a branded oral solution containing ethosuximide. Other ethosuximide oral solutions or capsules may be available in some markets, but product names, concentrations, excipients and authorized formulations can differ.
Do not assume that another product is interchangeable solely because it contains ethosuximide. Ask a pharmacist or prescriber to confirm the appropriate formulation and concentration.
| Target Market | Availability Considerations |
|---|---|
| United States | Verify brand recognition, approved alternatives and prescription/import requirements. |
| United Kingdom | Confirm local supply, product authorization and dispensing requirements. |
| Australia | Check current registration, supply channels and import eligibility. |
| UAE / Dubai / Gulf | Confirm local medicine regulations and import documentation. |
| Germany | Verify authorized formulations and local pharmacy supply. |
| France | Confirm national authorization and dispensing requirements. |
| Russia | Check current registration, supplier eligibility and import rules. |
| South Korea | Verify product authorization and applicable import requirements. |
| Canada | Confirm authorized products and prescription requirements. |
| Japan | Check local authorization and permitted import channels. |
| Other Markets | Availability depends on national regulations and verified supply channels. |
This table describes markets to investigate; it does not confirm that Absenz is authorized, stocked or legally importable in each country.
1. What is Absenz Oral Solution used for?
It contains ethosuximide, an anticonvulsant prescribed to control absence seizures.
2. What is the strength of Absenz Oral Solution?
The listed concentration is 50 mg/mL, equivalent to 250 mg per 5 mL. Check the product label before use.
3. What is the price of Absenz Oral Solution?
Price depends on pack size, supplier, stock status and destination. Request a current quotation before placing an order.
4. Can I buy Absenz Oral Solution online?
Online supply may be subject to a valid prescription, supplier eligibility and destination-country regulations. Confirm these requirements before ordering.
5. Is Absenz available internationally?
International availability is not guaranteed. Local authorization, supplier stock, shipping restrictions and import rules must be checked for each destination.
6. Can Absenz Oral Solution replace ethosuximide capsules?
A prescriber or pharmacist should confirm the appropriate formulation and dose before any change. Do not switch formulations without professional guidance.
7. How should Absenz Oral Solution be stored?
Follow the storage instructions on the product label and package leaflet. Keep the medicine securely out of the reach of children.
This page provides general product information and is not a substitute for professional medical advice, diagnosis or treatment. Ethosuximide should be used only under appropriate medical supervision. Product authorization, pricing and availability may change.
Last Updated: October 24, 2026
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.